Your browser doesn't support javascript.
loading
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study.
Rini, Brian I; Pal, Sumanta K; Escudier, Bernard J; Atkins, Michael B; Hutson, Thomas E; Porta, Camillo; Verzoni, Elena; Needle, Michael N; McDermott, David F.
Affiliation
  • Rini BI; Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: rinib2@ccf.org.
  • Pal SK; Kidney Cancer Program, City of Hope National Medical Center, Duarte, CA, USA.
  • Escudier BJ; Department of Oncology Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Atkins MB; Department of Medical Oncology, Georgetown Lombardi University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Hutson TE; Urologic Oncology, Baylor Sammons Cancer Center-Texas Oncology, Dallas, TX, USA.
  • Porta C; Department of Internal Medicine, University of Pavia Chief, Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
  • Verzoni E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Needle MN; AVEO Oncology, Cambridge, MA, USA.
  • McDermott DF; Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Lancet Oncol ; 21(1): 95-104, 2020 01.
Article in En | MEDLINE | ID: mdl-31810797
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Kidney Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Kidney Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article